SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
CMUV Bancorp (CMUV) trades at a trailing P/E of 11.9. Trailing earnings yield is 8.41%. PEG 0.96 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (11.9); PEG ≤ 1.0 — Peter Lynch undervalued (0.96); earnings yield beats bond yields (8.41%).
- PEG Ratio 0.96 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.41% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CMUV
Valuation Multiples
P/E (TTM)11.9
Forward P/EN/A
PEG Ratio0.96
Forward PEGN/A
P/B Ratio0.00
P/S Ratio2.39
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.08
Book Value / Share$0.00
Revenue / Share$10.36
FCF / Share$0.00
Yields & Fair Value
Earnings Yield8.41%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.56 |
$6.02M |
$1.12M |
18.6% |
| 2016 |
$0.69 |
$8.06M |
$1.51M |
18.7% |
| 2017 |
$0.65 |
$8.91M |
$1.43M |
16.1% |
| 2018 |
$0.88 |
$9.46M |
$2M |
21.2% |
| 2019 |
$1.02 |
$10.85M |
$2.32M |
21.4% |
| 2020 |
$1.45 |
$10.48M |
$3.33M |
31.8% |
| 2021 |
$2.21 |
$13.21M |
$5.07M |
38.4% |
| 2022 |
$1.92 |
$11.73M |
$3.69M |
31.5% |
| 2023 |
$1.85 |
$12.35M |
$3.51M |
28.4% |
| 2024 |
$2.08 |
$18.75M |
$3.77M |
20.1% |
